Disruption of COMMD1 accelerates diabetic atherosclerosis by promoting glycolysis

Diab Vasc Dis Res. 2023 Jan-Feb;20(1):14791641231159009. doi: 10.1177/14791641231159009.

Abstract

Aims: Diabetes will lead to serious complications, of which atherosclerosis is the most dangerous. This study aimed to explore the mechanisms of diabetic atherosclerosis.

Methods: ApoE-/- mice were fed with an high-fat diet diet and injected with streptozotocin to establish an in vivo diabetic atherosclerotic model. RAW 264.7 cells were treated with oxidized low-density lipoprotein particles (ox-LDL) and high glucose to produce an in vitro diabetic atherosclerotic model.

Results: In this study, we showed that diabetes promoted the progression of atherosclerosis in ApoE-/- mice and that high glucose potentiates macrophage proinflammatory activation and foam cell formation. Mechanistically, Copper metabolism MURR1 domain-containing 1(COMMD1) deficiency increased proinflammatory activation and foam cell formation, characterized by increased glycolysis, and then accelerated the process of atherosclerosis. Furthermore, 2-Deoxy-D-glucose (2-DG) reversed this effect.

Conclusion: Taken together, we provided evidence that the lack of COMMD1 accelerates diabetic atherosclerosis via mediating the metabolic reprogramming of macrophages. Our study provides evidence of a protective role for COMMD1 and establishes COMMD1 as a potential therapeutic strategy in patients with diabetic atherosclerosis.

Keywords: COMMD1; atherosclerosis; diabetes; glycolysis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Signal Transducing* / metabolism
  • Animals
  • Atherosclerosis* / metabolism
  • Diabetes Mellitus* / metabolism
  • Glucose / metabolism
  • Lipoproteins, LDL / metabolism
  • Macrophages / metabolism
  • Mice
  • Mice, Knockout, ApoE

Substances

  • Adaptor Proteins, Signal Transducing
  • Commd1 protein, mouse
  • Glucose
  • Lipoproteins, LDL